Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

Observations placeholder




Type of Spiritual Experience


Number of hallucinations: 24


A description of the experience

Flecainide acetate 

Flecainide was originally sold under the trade name Tambocor and is available under the trade names Almarytm, Apocard, Ecrinal, and Flécaine.

It is an antiarrhythmic agent  used to prevent and treat tachyarrhythmias (abnormal fast rhythms of the heart), including paroxysmal atrial fibrillation (episodic irregular heartbeat originating in the upper chamber of the heart), paroxysmal supraventricular tachycardia (episodic rapid but regular heartbeat originating in the atrium), and ventricular tachycardia (rapid rhythms of the lower chambers of the heart). Flecainide works by blocking the Nav1.5 sodium channel in the heart, causing prolongation of the cardiac action potential.   This thereby slows conduction of the electrical impulse within the heart.

The dosing of flecainide is rather critical and should take into account the individual's other medications and comorbid conditions and how they may affect the metabolism of flecainide. Flecainide interacts with numerous pharmaceuticals and can potentiate the effects of other myocardial depressants and AV node blocking agents. In addition, flecainide can decrease the metabolism or elimination of many (but not all) agents that use the cytochrome P450 enzyme system.

At the wrong dosage the drug is a toxin.  It can kill you.  “Studies have shown an increased mortality when flecainide is used to suppress ventricular extrasystoles in the setting of acute myocardial infarction” and “Due to the narrow therapeutic index of flecainide, physicians should be alert for signs of toxicity before life-threatening arrhythmias occur

Furthermore, the results of a medical study known as the Cardiac Arrhythmia Suppression Trial (CAST) demonstrated that patients with structural heart disease and ventricular arrhythmias, could suffer a fatal arrhythmia.

On Jan, 08, 2017 1,718 people reported to have side effects when taking Tambocor.  Among them, 7 people (0.41%) have Hallucination.

On Jan, 29, 2017 1,718 people reported to have side effects when taking Tambocor.
Among them, 3 people (0.17%) have Hallucination, Auditory

On Jan, 04, 2017 3,629 people reported to have side effects when taking Flecainide Acetate.  Among them, 14 people (0.39%) have Hallucination



On Mar, 27, 2015: 1,374 people reported to have side effects when taking Tambocor. Among them, 20 people (1.46%) have Death.

Time on Tambocor when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 71.43% 14.29% 0.00% 0.00% 14.29% 0.00% 0.00%

The source of the experience


Concepts, symbols and science items



Science Items

Activities and commonsteps



Anti-arrhythmia drugs
Heart arrythmia